We have the ability to understand and troubleshoot complex medicinal chemistry problems due to our strong research backgrounds and extensive experience in a wide variety of therapeutic drug discovery programs such as oncology, central nervous system disorders, HIV/AIDS, cardiovascular and metabolic diseases, anti-psychotics, gastrointestinal conditions, inflammation, anti-infectives and Alzheimer’s disease.
GL CHEMTEC is -- Experienced in the biology, pharmacology, and intellectual property (IP) associated with drug discovery and development.
- Focused on library design and lead generation from clients’ scaffolds.
- Structure-activity Relationship (SAR) developers targeting lead optimization.
- In-house experts in metabolic evaluation that complements our internal synthetic chemistry capabilities to target libraries with higher overall success rates.
- An CRO with full in-house analytical support.
- Once a client has identified a hit (or hit series), a full medicinal chemistry evaluation will be conducted.
- A diverse, defined library will be enumerated to explore the chemical space around the hit, bearing in mind any (IP) and synthetic limitations.
- Using all available literature information, a vast array of synthetic routes will be explored and developed.
- With this information, a hit library will be synthesized and delivered to the client.
- Once a lead has been selected, a focused library centering on the lead will be enumerated and synthesized for lead optimization.
- A definable SAR is developed.
- ADME optimization and other physical chemical properties are evaluated and taken into account in the library design.
- A lead optimization library will be synthesized and delivered to the client.
- Alternative library iterations may be utilized.
- Hit analogue (or library) design and synthesis
- Lead optimization
- IP evaluation and write-up
- Pre-clinical scale-up
- Alternative therapeutic programs
- Key intermediates and scale-up
- Back-up compounds
- Additional medicinal chemical space coverage
